BLOG

Fierce-Biotech

Outsmarting cancer with RNA, ‘genome-tuning’ drugs and other gene-altering therapies

OncoSec’s DNA-delivery system is designed to prompt the body to make more of its own IL-12. “The DNA essentially co-opts the cell’s function to cause it to make IL-12,” explained Daniel O’Connor, former CEO of OncoSec, in an interview.